News

According to data compiled by Bloomberg, Endo Pharmaceuticals has completed six deals in the past five years, with an average size of $352.8m and a typical premium of

Caliper Life Sciences president and CEO Kevin Hrusovsky said the deal will improve the economics of diagnostic testing and advance the worldwide implementation of personalised medicine. "We believe

The GeneAtlas System is the first personal microarray system, designed to meet the demand for an easy to use and affordable way to interrogate the whole genome. The

The company has said that it will conduct the trial following US Food and Drug Administration clearance of its Investigational New Drug application (IND). The clinical study is

Merck and Parexel said that under the contract, a Merck BioVentures unit will be established within the Parexel organization. Parexel chairman and CEO Josef von Rickenbach said they

Most recently, Devlin worked as the vice president of Abbott where she led Global Pipeline Marketing for all therapeutic areas, including oncology. Devlin held positions as vice president

As per the terms of the agreement, Nycomed is expected to take up the responsibility of marketing and distributing Zenpep (pancrelipase) delayed-Release capsules in Russia and CIS, as

In the trial, the company has involved patients previously treated with locally advanced or metastatic, non-squamous non-small cell lung cancer (NSCLC) who will receive ARQ 197 plus erlotinib

Under the agreement, SCRI will partner with AstraZeneca to provide clinical programme development expertise, clinical programme design, medical oversight and trial management. The first clinical trial to be